A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes

• Status: Completed
• Trial end date: 2021-01-10
• Target enrollment: 0
• Participant gender: All

Summary

This is a single center, double-blind, randomized trial in subjects with type 1 diabetes mellitus applying an adaptive design approach.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Abvance Therapeutics
• Collaborator: T1D Exchange, United States
• Treatments: Glucagon; Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Male or female patients aged between 18 and 64 years (both inclusive)

• Type 1 diabetes mellitus (as diagnosed clinically) ≥ 12 months prior to the screening visit

• Treated with daily insulin for T1DM ≥ 12 months prior to the screening visit

Exclusion Criteria:

-